Cancer Therapy

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious long-term urinary and bowel complications, according to results of a meta-analysis published in Lancet Oncology.

Debra Patt, MD, PhD, MBA, FASCO, has often found her career has placed her at the intersection of public policy and clinical informatics.

In this video, Arvind N. Dasari, MD, MS, discussed the results of the CheckMate 8HW trial in which nivolumab and ipilimumab were compared with nivolumab monotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer.

Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with pancreatic cancer or other gastrointestinal malignancies.

Cancer treatment, primarily chemotherapy, is associated with impaired cardiorespiratory fitness years after treatment has ended and regardless of cancer subtype, according to a meta-analysis published in JACC: CardioOncology.

Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to results of a meta-analysis.

Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related cardiac events than those treated with other EGFR tyrosine kinase inhibitors.

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.

Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose methotrexate, according to results of a large, multicenter observational study.

Men treated with radiotherapy and prostatectomy for prostate cancer exhibit significantly higher risk for numerous urinary and sexual complications compared with the general population, according to results of a cohort study.